Recent advances in DNA vaccines for autoimmune diseases

References

• Fernando MM, Stevens CR, Walsh EC et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet.4(4), E1000024 (2008).
   PubMed Web of Science ®Google Scholar
• Kohm AP, Fuller KG, Miller SD. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol.11(3), 101–105 (2003).
   PubMed Web of Science ®Google Scholar
• Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented antigen from damaged pancreatic β cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest.109(1), 79–87 (2002).
   PubMed Web of Science ®Google Scholar
• Garn H, Renz H. Epidemiological and immunological evidence for the hygiene hypothesis. Immunobiology212(6), 441–452 (2007).
   PubMed Web of Science ®Google Scholar
• Zaccone P, Fehervari Z, Phillips JM, Dunne DW, Cooke A. Parasitic worms and inflammatory diseases. Parasite Immunol.28(10), 515–523 (2006).
   PubMed Web of Science ®Google Scholar
• Sewell DL, Reinke EK, Hogan LH, Sandor M, Fabry Z. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol. Lett.82(1–2), 101–110 (2002).
   PubMed Web of Science ®Google Scholar
• Rook GA. The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders. Trans. R. Soc. Trop. Med. Hyg.101(11), 1072–1074 (2007).
   PubMed Web of Science ®Google Scholar
• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature423(6937), 356–361 (2003).
   PubMed Web of Science ®Google Scholar
• Lebre MC, Tak PP. Dendritic cell subsets: their roles in rheumatoid arthritis. Acta Rheumatol. Port.33(1), 35–45 (2008).
   PubMed Web of Science ®Google Scholar
• Sato K. Th17 cells and rheumatoid arthritis – from the standpoint of osteoclast differentiation. Allergol. Int.57(2), 109–114 (2008).
   PubMedGoogle Scholar
• Morgan ME, Flierman R, van Duivenvoorde LM et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum.52(7), 2212–2221 (2005).
   PubMed Web of Science ®Google Scholar
• Cao D, van Vollenhoven R, Klareskog L, Trollmo C, Malmström V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther.6(4), R335–R346 (2004).
   PubMedGoogle Scholar
• Liu MF, Wang CR, Fung LL, Lin LH, Tsai CN. The presence of cytokine-suppressive CD4+CD25+ T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand. J. Immunol.62(3), 312–317 (2005).
   PubMed Web of Science ®Google Scholar
• Chentoufi AA, Binder NR, Berka N, Abunadi T, Polychronakos C. Advances in Type I diabetes associated tolerance mechanisms. Scand. J. Immunol.68(1), 1–11 (2008).
   PubMedGoogle Scholar
• Jaeckel E, Mpofu N, Saal N, Manns MP. Role of regulatory T cells for the treatment of Type 1 diabetes mellitus. Horm. Metab. Res.40(2), 126–136 (2008).
   PubMedGoogle Scholar
• Bluestone JA, Tang Q, Sedwick CE. T regulatory cells in autoimmune diabetes: past challenges, future prospects. J. Clin. Immunol.28(6), 677–684 (2008).
   PubMed Web of Science ®Google Scholar
• Manirarora JN, Kosiewicz MM, Parnell SA, Alard P. APC activation restores functional CD4+CD25+ regulatory T cells in NOD mice that can prevent diabetes development. PLoS ONE3(11), E3739 (2008).
   Google Scholar
• Walker LS. Natural Treg in autoimmune diabetes: all present and correct? Expert Opin. Biol. Ther.8(11), 1691–1703 (2008).
   PubMed Web of Science ®Google Scholar
• Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, Buckner JH. The effector T cells of diabetic subjects are resistant to regulation via CD4+ Foxp3+ regulatory T cells. J. Immunol.181(10), 7350–7355 (2008).
   PubMed Web of Science ®Google Scholar
• Dhib-Jalbut S. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis. Neurology68(22 Suppl. 3), S13–S21 (2007).
   PubMed Web of Science ®Google Scholar
• Holmoy T, Hestvik AL. Multiple sclerosis: immunopathogenesis and controversies in defining the cause. Curr. Opin. Infect. Dis.21(3), 271–278 (2008).
   PubMed Web of Science ®Google Scholar
• Zozulya AL, Wiendl H. The role of regulatory T cells in multiple sclerosis. Nat. Clin. Pract. Neurol.4(7), 384–398 (2008).
   PubMedGoogle Scholar
• Mauri C, Ehrenstein MR. The ‘short’ history of regulatory B cells. Trends Immunol.29(1), 34–40 (2008).
   PubMed Web of Science ®Google Scholar
• Jolicoeur C, Hanahan D, Smith KM. T-cell tolerance toward a transgenic β-cell antigen and transcription of endogenous pancreatic genes in thymus. Proc. Natl Acad. Sci. USA91(14), 6707–6711 (1994).
   PubMed Web of Science ®Google Scholar
• Gotter J, Brors B, Hergenhahn M, Kyewski B. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J. Exp. Med.199(2), 155–166 (2004).
   PubMed Web of Science ®Google Scholar
• Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat. Rev. Immunol.6(10), 728–740 (2006).
   PubMed Web of Science ®Google Scholar
• Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol.7(8), 585–598 (2007).
   PubMed Web of Science ®Google Scholar
• Liotta F, Cosmi L, Romagnani P, Maggi E, Romagnani S, Annunziato F. Functional features of human CD25+ regulatory thymocytes. Microbes Infect.7(7–8), 1017–1022 (2005).
   PubMedGoogle Scholar
• Igarashi H, Cao Y, Iwai H et al. GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells. Biochem. Biophys. Res. Commun. 369(4), 1134–1138 (2008).
   PubMed Web of Science ®Google Scholar
• Zheng Y, Manzotti CN, Burke F et al. Acquisition of suppressive function by activated human CD4+ CD25- T cells is associated with the expression of CTLA-4 not FoxP3. J. Immunol.181(3), 1683–1691 (2008).
   PubMed Web of Science ®Google Scholar
• Mazzucchelli R, Hixon JA, Spolski R et al. Development of regulatory T cells requires IL-7Rα stimulation by IL-7 or TSLP. Blood112(8), 3283–3292 (2008).
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.4(4), 330–336 (2003).
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science299(5609), 1057–1061 (2003).
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol.4(4), 337–342 (2003).
   PubMed Web of Science ®Google Scholar
• Roncarolo MG, Gregori S. Is FOXP3 a bona fide marker for human regulatory T cells? Eur. J. Immunol.38(4), 925–927 (2008).
   PubMed Web of Science ®Google Scholar
• Coombes JL, Siddiqui KR, Arancibia-Carcamo CV et al. A functionally specialized population of mucosal CD103-DCs induces Foxp3-regulatory T cells via a TGFβ and retinoic acid-dependent mechanism. J. Exp. Med.204, 1757–1764 (2007).
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Dudziak D, Heidkamp GF et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol.181(10), 6923–6933 (2008).
   PubMed Web of Science ®Google Scholar
• Huber S, Schramm C. TGF-β and CD4+CD25+ regulatory T cells. Front. Biosc.11, 1014–1023 (2006).
   PubMed Web of Science ®Google Scholar
• Scheffold A, Murphy KM, Höfer T. Competition for cytokines: Treg cells take all. Nat. Immunol.8(12), 1285–1287 (2007).
   PubMedGoogle Scholar
• Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression – a diverse arsenal for a moving target. Immunology124(1), 13–22 (2008).
   PubMed Web of Science ®Google Scholar
• Minguet S, Huber M, Rosenkranz L, Schamel WW, Reth M, Brummer T. Adenosine and cAMP are potent inhibitors of the NF-κ B pathway downstream of immunoreceptors. Eur. J. Immunol.35(1), 31–41 (2005).
   PubMed Web of Science ®Google Scholar
• Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med.190(7), 995–1004 (1999).
   PubMed Web of Science ®Google Scholar
• Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells. J. Exp. Med.183(6), 2669–2674 (1996).
   PubMed Web of Science ®Google Scholar
• Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat. Immunol.8(12), 1353–1362 (2007).
   PubMed Web of Science ®Google Scholar
• Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat. Rev. Immunol.7(9), 665–677 (2007).
   PubMed Web of Science ®Google Scholar
• Stewart AJ, Devlin PM. The history of the smallpox vaccine. J. Infect.52(5), 329–334 (2006).
   PubMed Web of Science ®Google Scholar
• Schwartz M. Institut Pasteur: 120 years of research in microbiology. Res. Microbiol.159(1), 5–14 (2008).
   PubMedGoogle Scholar
• Steinman RM. Dendritic cells and vaccine. Proc. (Bayl. Univ. Med. Cent.)21(1), 3–8 (2008).
   PubMedGoogle Scholar
• Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science247(4949 Pt 1), 1465–1468 (1990).
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science259(5102), 1745–1749 (1993).
   PubMed Web of Science ®Google Scholar
• Laddy DJ, Weiner DB. From plasmids to protection: a review of DNA vaccines against infectious diseases. Int. Rev. Immunol.25(3–4), 99–123 (2006).
   PubMed Web of Science ®Google Scholar
• Lowrie DB, Silva CL, Colston MJ, Ragno S, Tascon RE. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine15(8), 834–838 (1997).
   PubMed Web of Science ®Google Scholar
• Lowrie DB, Tascon RE, Bonato VL et al. Therapy of tuberculosis in mice by DNA vaccination. Nature400(6741), 269–271 (1999).
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat. Rev. Genet.9(10), 776–788 (2008).
   PubMed Web of Science ®Google Scholar
• Lu S, Wang S, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans. Expert Rev. Vaccines7(2), 175–191 (2008).
   PubMed Web of Science ®Google Scholar
• Basner-Tschakarjan E, Mirmohammadsadegh A, Baer A, Hengge UR. Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins. Gene Ther.11(9), 765–774 (2004).
   PubMed Web of Science ®Google Scholar
• Jozefowski S, Sulahian TH, Arredouani M, Kobzik L. Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides. J. Leukoc. Biol.80(4), 870–879 (2006).
   PubMed Web of Science ®Google Scholar
• Trombone AP, Silva CL, Lima KM et al. Endocytosis of DNA-Hsp65 alters the pH of the late endosome/lysosome and interferes with antigen presentation. PLoS ONE2(9), E923 (2007).
   PubMedGoogle Scholar
• Lechardeur D, Verkman AS, Lukacs GL. Intracellular routing of plasmid DNA during non-viral gene transfer. Adv. Drug Deliv. Rev.57(5), 755–767 (2005).
   PubMed Web of Science ®Google Scholar
• Lechardeur D, Lukacs GL. Nucleocytoplasmic transport of plasmid DNA: a perilous journey from the cytoplasm to the nucleus. Hum. Gene Ther.17(9), 882–889 (2006).
   PubMed Web of Science ®Google Scholar
• Belakova J, Horynova M, Krupka M, Weigl E, Raska M. DNA vaccines: are they still just a powerful tool for the future? Arch. Immunol. Ther. Exp. (Warsz.)55(6), 387–398 (2007).
   PubMed Web of Science ®Google Scholar
• Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature408(6813), 740–745 (2000).
   PubMed Web of Science ®Google Scholar
• Latz E, Schoenemeyer A, Visintin A et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol.5(2), 190–198 (2004).
   PubMed Web of Science ®Google Scholar
• Hacker H, Vabulas RM, Takeuchi O et al. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med.192(4), 595–600 (2000).
   PubMed Web of Science ®Google Scholar
• Takeshita F, Ishii KJ, Ueda A, Ishigatsubo Y, Klinman DM. Positive and negative regulatory elements contribute to CpG oligonucleotide-mediated regulation of human IL-6 gene expression. Eur. J. Immunol.30(1), 108–116 (2000).
   PubMedGoogle Scholar
• Takeshita F, Klinman DM. CpG ODN-mediated regulation of IL-12 p40 transcription. Eur. J. Immunol.30(7), 1967–1976 (2000).
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sato S, Mori K et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol.169(12), 6668–6672 (2002).
   PubMed Web of Science ®Google Scholar
• Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol.157(5), 1840–1845 (1996).
   PubMed Web of Science ®Google Scholar
• Krieg AM, Yi AK, Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature374(6522), 546–549 (1995).
   PubMed Web of Science ®Google Scholar
• Agrawal S, Kandimalla ER. Modulation of Toll-like receptor 9 responses through synthetic immunostimulatory motifs of DNA. Ann. NY Acad. Sci.1002, 30–42 (2003).
   PubMed Web of Science ®Google Scholar
• Franco LH, Wowk PF, Silva CL et al. A DNA vaccine against tuberculosis based on the 65 kDa heat-shock protein differentially activates human macrophages and dendritic cells. Genet. Vaccines Ther.6, 3 (2008).
   PubMedGoogle Scholar
• Ishii KJ, Kawagoe T, Koyama S et al. TANK-biding kinase 1 delineates innate and adaptive immune responses to DNA vaccines. Nature451, 725–729 (2008).
   PubMed Web of Science ®Google Scholar
• Pertmer TM, Roberts TR, Haynes JR. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol.70(9), 6119–6125 (1996).
   PubMed Web of Science ®Google Scholar
• Li L, Boussiotis VA. Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications. J. Mol. Med.84(11), 887–899 (2006).
   PubMed Web of Science ®Google Scholar
• Mimran A, Mor F, Carmi P, Quintana FJ, Rotter V, Cohen IR. DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response. J. Clin. Invest.113(6), 924–932 (2004).
   PubMed Web of Science ®Google Scholar
• Linsen L, Somers V, Stinissen P. Immunoregulation of autoimmunity by natural killer T cells. Hum. Immunol.66(12), 1193–1202 (2005).
   PubMed Web of Science ®Google Scholar
• Awasthi A, Murugaiyan G, Kuchroo VK. Interplay between effector Th17 and regulatory T cells. J. Clin. Immunol.28(6), 660–670 (2008).
   PubMed Web of Science ®Google Scholar
• Nikoopour E, Schwartz JA, Singh B. Therapeutic benefits of regulating inflammation in autoimmunity. Inflamm. Allergy Drug Targets7(3), 203–210 (2008).
   PubMedGoogle Scholar
• Ferrera F, La Cava A, Rizzi M, Hahn BH, Indiveri F, Filaci G. Gene vaccination for the induction of immune tolerance. Ann. NY Acad. Sci.1110, 99–111 (2007).
   PubMed Web of Science ®Google Scholar
• Harrison LC. Vaccination against self to prevent autoimmune diseases: the Type 1 diabetes model. Immunol. Cell Biol.86, 139–145 (2008).
   PubMedGoogle Scholar
• Ho PP, Higgins JP, Kidd BA et al. Tolerizing DNA vaccines for autoimmune arthritis. Autoimmunity39(8), 675–682 (2006).
   PubMed Web of Science ®Google Scholar
• Tisch R, Wang B, Weaver DJ et al. Antigen-specific mediated suppression of β cell autoimmunity by plasmid DNA vaccination. J. Immunol.166(3), 2122–2132 (2001).
   PubMed Web of Science ®Google Scholar
• Bot A, Smith D, Bot S et al. Plasmid vaccination with insulin β chain prevents autoimmune diabetes in nonobese diabetic mice. J. Immunol.167(5), 2950–2955 (2001).
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Carmi P, Cohen IR. DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes. J. Immunol.169(10), 6030–6035 (2002).
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Rotem A, Carmi P, Cohen IR. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. J. Immunol.165(11), 6148–6155 (2000).
   PubMed Web of Science ®Google Scholar
• Weaver DJ Jr, Liu B, Tisch R. Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice. J. Immunol.167(1), 586–592 (2001).
   PubMed Web of Science ®Google Scholar
• Ruiz PJ, Garren H, Ruiz IU et al. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. J. Immunol.162(6), 3336–3341 (1999).
   PubMed Web of Science ®Google Scholar
• Garren H, Ruiz PJ, Watkins TA et al. Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. Immunity15(1), 15–22 (2001).
   PubMed Web of Science ®Google Scholar
• Robinson WH, Fontoura P, Lee BJ et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol.21(9), 1033–1039 (2003).
   PubMed Web of Science ®Google Scholar
• Bar-Or A, Vollmer T, Antel J et al. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled Phase 1/2 trial. Arch. Neurol.64(10), 1407–1415 (2007).
   PubMed Web of Science ®Google Scholar
• Silver PB, Agarwal RK, Su SB et al. Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J. Immunol.179(8), 5146–5158 (2007).
   PubMed Web of Science ®Google Scholar
• Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN. Regulatory T cells and human disease. Clin. Dev. Immunol.2007, 89195 (2007).
   PubMedGoogle Scholar
• Jin H, Kang Y, Zheng G et al. Induction of active immune suppression by co-immunization with DNA- and protein-based vaccines. Virology337(1), 183–191 (2005).
   PubMedGoogle Scholar
• Kang Y, Jin H, Zheng G et al. Co-inoculation of DNA and protein vaccines induces antigen-specific T cell suppression. Biochem. Biophys. Res. Commun.353(4), 1034–1039 (2007).
   PubMedGoogle Scholar
• Schif-Zuck S, Wildbaum G, Karin N. Coadministration of plasmid DNA constructs encoding an encephalitogenic determinant and IL-10 elicits regulatory T cell-mediated protective immunity in the central nervous system. J. Immunol.177(11), 8241–8247 (2006).
   PubMedGoogle Scholar
• Eggena MP, Walker LS, Nagabhushanam V, Barron L, Chodos A, Abbas AK. Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen. J. Exp. Med.199(12), 1725–1730 (2004).
   PubMed Web of Science ®Google Scholar
• Li AF, Hough J, Henderson D, Escher A. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Vaccine22(13–14), 1751–1763 (2004).
   PubMed Web of Science ®Google Scholar
• Bárdos T, Czipri M, Vermes C, Zhang J, Mikecz K, Glant TT. Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice. Clin. Exp. Immunol.129(2), 224–231 (2002).
   PubMedGoogle Scholar
• Lindquist S. The heat-shock response. Annu. Rev. Biochem.55, 1151–1191 (1986).
   PubMed Web of Science ®Google Scholar
• Lindquist JA, Jensen ON, Mann M, Hämmerling GJ. ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J.17(8), 2186–2195 (1998).
   PubMedGoogle Scholar
• Li Z, Srivastava P. Heat-shock proteins. Curr. Protoc. Immunol. Appendix 1T (2004).
   PubMedGoogle Scholar
• Anderton SM, van der Zee R, Prakken B, Noordzij A, van Eden W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J. Exp. Med.181(3), 943–952 (1995).
   PubMed Web of Science ®Google Scholar
• Birk OS, Elias D, Weiss AS et al. NOD mouse diabetes: the ubiquitous mouse hsp60 is a β-cell target antigen of autoimmune T cells. J. Autoimmun.9(2), 159–166 (1996).
   PubMedGoogle Scholar
• Birnbaum G, Kotilinek L, Miller SD et al. Heat shock proteins and experimental autoimmune encephalomyelitis. II: environmental infection and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis. J. Neuroimmunol.90(2), 149–161 (1998).
   PubMed Web of Science ®Google Scholar
• Jorgensen C, Gedon E, Jaquet C, Sany J. Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice. J. Rheumatol.25(4), 763–767 (1998).
   PubMedGoogle Scholar
• Thompson SJ, Butcher PD, Patel VK et al. Modulation of pristane-induced arthritis by mycobacterial antigens. Autoimmunity11(1), 35–43 (1991).
   PubMed Web of Science ®Google Scholar
• Hauet-Broere F, Wieten L, Guichelaar T, Berlo S, van der Zee R, Van Eden W. Heat shock proteins induce T cell regulation of chronic inflammation. Ann. Rheum. Dis.65(Suppl. 3), iii65–iii68 (2006).
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Carmi P, Mor F, Cohen IR. DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide. J. Immunol.171(7), 3533–3541 (2003).
   PubMed Web of Science ®Google Scholar
• Nussbaum G, Zanin-Zhorov A, Quintana F, Lider O, Cohen IR. Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis. Int. Immunol.18(10), 1413–1419 (2006).
   PubMed Web of Science ®Google Scholar
• Willem van Eden Immunoregulation of autoimmune diseases. Hum. Immunol.67, 446–453 (2006).
   PubMedGoogle Scholar
• Quintana FJ, Carmi P, Mor F, Cohen IR. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kD or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kD heat-shock protein. Arthritis Rheum.50(11), 3712–3720 (2004).
   PubMed Web of Science ®Google Scholar
• Bandholtz L, Guo Y, Palmberg C et al. Hsp90 binds CpG oligonucleotides directly: implications for Hsp90 as a missing link in CpG signaling and recognition. Cell. Mol. Life Sci.60, 422–429 (2003).
   PubMedGoogle Scholar
• Lukacs KV, Lowrie DB, Stokes RW et al. Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors. J. Exp. Med.178, 343–348 (1993).
   PubMed Web of Science ®Google Scholar
• Castelli C, Rivoltini L, Rini F et al. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol. Immunother.53, 227–233 (2004).
   PubMed Web of Science ®Google Scholar
• Jones DB, Coulson AF, Duff GW. Sequence homologies between Hsp60 and autoantigens. Immunol. Today14(3), 115–118 (1993).
   PubMedGoogle Scholar
• Raska M, Weigl E. Heat shock proteins in autoimmune diseases. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub.149(2), 243–249 (2005).
   PubMedGoogle Scholar
• Perschinka H, Mayr M, Millonig G et al. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler. Thromb. Vasc. Biol.23(6), 1060–1065 (2003).
   PubMed Web of Science ®Google Scholar
• Weiner GJ. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J. Leukoc. Biol.68(4), 455–463 (2000).
   PubMed Web of Science ®Google Scholar
• Roberts TL, Dunn JA, Terry TD et al. Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides. J. Immunol.175(6), 3569–3576 (2005).
   PubMedGoogle Scholar
• Cornelie S, Poulain-Godefroy O, Lund C et al. Methylated CpG-containing plasmid activates the immune system. Scand. J. Immunol.59(2), 143–151 (2004).
   PubMed Web of Science ®Google Scholar
• Santos-Junior RR, Sartori A, De Franco M et al. Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis. Hum. Gene Ther.16(11), 1338–1345 (2005).
   PubMedGoogle Scholar
• Vigar ND, Cabrera WH, Araujo LM et al. Pristane-induced arthritis in mice selected for maximal or minimal acute inflammatory reaction. Eur. J. Immunol.30(2), 431–437 (2000).
   PubMed Web of Science ®Google Scholar
• Krieg AM. From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA. Antisense Nucleic Acid Drug. Dev.11(3), 181–188 (2001).
   PubMedGoogle Scholar
• Roberts TL, Sweet MJ, Hume DA et al. Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides. J. Immunol.174(2), 605–608 (2005).
   PubMed Web of Science ®Google Scholar
• Santos-Junior RR, Sartori A, Bonato VL et al. Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression. Clin. Exp. Immunol.149(3), 570–578 (2007).
   PubMedGoogle Scholar
• Pashine A, Valiante NM, Ulmer JB. Targeting the innate immune response with improved vaccine adjuvants. Nat. Med.11(4 Suppl.), S63–S68 (2005).
   PubMed Web of Science ®Google Scholar
• Duramad O, Fearon KL, Chang B et al. Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation. J. Immunol.174, 5193 (2005).
   PubMed Web of Science ®Google Scholar
• Krieg AM, Wu T, Weeratna R et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl Acad. Sci. USA95(21), 12631–12636 (1998).
   PubMed Web of Science ®Google Scholar
• Pisetsky DS, Reich CF. Inhibition of murine macrophage IL-12 production by natural and synthetic DNA. Clin. Immunol.96(3), 198–204 (2000).
   PubMed Web of Science ®Google Scholar
• Chen Y, Lenert P, Weeratna R et al. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther.8(13), 1024–1032 (2001).
   PubMed Web of Science ®Google Scholar
• Gursel I, Gursel M, Yamada H, Ishii KJ, Takeshita F, Klinman DM. Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J. Immunol.171(3), 1393–1400 (2003).
   PubMed Web of Science ®Google Scholar
• Michaluart P, Abdallah KA, Lima FD et al. Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Ther.15(10), 676–684 (2008).
   PubMedGoogle Scholar
• Victora G, Socorro-Silva A, Volsi EC et al. Immune response to vaccination with DNA-hsp65 in a Phase I clinical trial with head and neck cancer patients. Cancer Gene Ther. (2009) (In Press).
   PubMedGoogle Scholar
• Li A, Ojogho O, Franco E, Baron P, Iwaki Y, Escher A. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces Foxp3+ regulatory T cells in vitro. Vaccine24(23), 5036–5046 (2006).
   PubMed Web of Science ®Google Scholar
• Chang Y, Yap S, Ge X et al. DNA vaccination with an insulin construct and a chimeric protein binding to both CTLA4 and CD40 ameliorates Type 1 diabetes in NOD mice. Gene Ther.12(23), 1679–1685 (2005).
   PubMedGoogle Scholar
• Luo JH, Zhou ZG, Jiang TJ et al. Mechanisms of human glutamic acid decarboxylase 65 DNA vaccine preventing diabetes in non-obese diabetic mice. Zhonghua Yi Xue Za Zhi.84(21), 1791–1795 (2004).
   PubMedGoogle Scholar
• Prud’homme GJ, Chang Y, Li X. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand. Hum. Gene Ther.13(3), 395–406 (2002).
   PubMed Web of Science ®Google Scholar
• Onodera S, Ohshima S, Tohyama H et al. A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis. Arthritis Rheum.56(2), 521–530 (2007).
   PubMed Web of Science ®Google Scholar
• Quintana FJ, Carmi P, Mor F, Cohen IR. Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J. Immunol.169(6), 3422–3428 (2002).
   PubMed Web of Science ®Google Scholar
• Wildbaum G, Westermann J, Maor G, Karin N. A targeted DNA vaccine encoding Fas ligand defines its dual role in the regulation of experimental autoimmune encephalomyelitis. J. Clin. Invest.106(5), 671–679 (2000).
   PubMed Web of Science ®Google Scholar
• Elkayam O, Yaron M, Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann. Rheum. Dis.61(7), 623–625 (2002).
   PubMed Web of Science ®Google Scholar
• Blank M, Krause I, Wildbaum G, Karin N, Shoenfeld Y. TNF-α DNA vaccination prevents clinical manifestations of experimental antiphospholipid syndrome. Lupus12(7), 546–549 (2003).
   PubMedGoogle Scholar
• Wildbaum G, Karin N. Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-α) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis. Gene Ther.6(6), 1128–1138 (1999).
   PubMed Web of Science ®Google Scholar
• Ho PP, Fontoura P, Platten M et al. A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune disease. J. Immunol.175(9), 6226–6234 (2005).
   PubMed Web of Science ®Google Scholar
• Lobell A, Weissert R, Eltayeb S, Svanholm C, Olsson T, Wigzell H. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis. J. Immunol.163(9), 4754–4762 (1999).
   PubMed Web of Science ®Google Scholar
• Garren H, Robinson WH, Krasulova E et al. Phase II trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann. Neurol.63(5), 611–620 (2008).
   PubMed Web of Science ®Google Scholar
• Garren H. A DNA vaccine for multiple sclerosis. Expert Opin. Biol. Ther.8(10), 1539–1550 (2008).
   PubMed Web of Science ®Google Scholar